National Bank of Canada
DFTX

National Bank of Canada’s Definium Therapeutics DFTX Stock Holding History

National Bank of Canada’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.3K Sell
1,708
-159
-9% -$2.7K ﹤0.01% 2074
2025
Q4 		$25K Buy
1,867
+276
+17% +$3.42K ﹤0.01% 2105
2025
Q3 		$18.7K Buy
1,591
+170
+12% +$1.58K ﹤0.01% 2168
2025
Q2 		$9.22K Hold
1,421
– – ﹤0.01% 2383
2025
Q1 		$8.31K Sell
1,421
-126
-8% -$902 ﹤0.01% 2282
2024
Q4 		$10.8K Buy
1,547
+77
+5% +$530 ﹤0.01% 2310
2024
Q3 		$8.36K Sell
1,470
-272
-16% -$1.89K ﹤0.01% 2122
2024
Q2 		$12.3K Hold
1,742
– – ﹤0.01% 2086
2024
Q1 		$16.1K Buy
1,742
+75
+4% +$428 ﹤0.01% 2074
2023
Q4 		$6K Buy
1,667
+33
+2% +$99 ﹤0.01% 2264
2023
Q3 		$4.95K Buy
1,634
+113
+7% +$464 ﹤0.01% 2351
2023
Q2 		$5.36K Sell
1,521
-46
-3% -$159 ﹤0.01% 2324
2023
Q1 		$4.89K Sell
1,567
-200
-11% -$665 ﹤0.01% 2296
2022
Q4 		$3.85K Buy
1,767
+25
+1% +$69 ﹤0.01% 2384
2022
Q3 		$6K Sell
1,742
-42
-2% -$403 ﹤0.01% 2309
2022
Q2 		$17K Sell
1,784
-450
-20% -$5.69K ﹤0.01% 2126
2022
Q1 		$37K Sell
2,234
-9,570
-81% -$166K ﹤0.01% 1978
2021
Q4 		$244K Buy
+11,804
New +$377K ﹤0.01% 1411

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

National Bank of Canada's DFTX Position: Q1 2026 in Review

National Bank of Canada reduced its Definium Therapeutics (DFTX) stake by 8.5% in Q1 2026, selling an estimated $2.7K and leaving 1,708 shares worth $32.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2074.

National Bank of Canada first reported a position in DFTX in Q4 2021 and has held it in 18 quarters since. The position peaked at $244K in Q4 2021. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • National Bank of Canada held 1,708 shares of Definium Therapeutics worth $32.3K as of Q1 2026.
  • National Bank of Canada sold 159 Definium Therapeutics shares in Q1 2026, an estimated $2.7K.
  • Definium Therapeutics made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2074 holding.
  • National Bank of Canada first reported a position in Definium Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's Definium Therapeutics position peaked at $244K in Q4 2021.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.